Meet your MIDD Dream Team at ACoP11

Accelerating Medicines to Patients in Partnership with You


At Certara, we help our partners think differently about crucial decisions and reach better outcomes, smarter and faster. We support confident decision-making throughout all phases of drug development, resulting in faster cycle times, lower costs, and better outcomes for patients.

How are we different?

  • 我们的定量驱动方法。Using modeling and simulation across the entire drug development life cycle, we help to de-risk your program, increase confidence in critical decisions, and help you reach your goals, smarter and faster.
  • 我们的员工。We have the most experienced (and largest) team of experts with clinical pharmacologists, pharmacometricians, and regulatory scientists and writers, that are dedicated to achieve your success.
  • 我们久经证明的成就记录。我们有一个案例研究库,内容涉及我们在肿瘤学、罕见病、传染病、神经退行性疾病等方面的成功合作。

We are excited to see you virtually at ACoP11.  From Certara, we are proud to have 18 speakers who will be participating and many more who will be at the conference to discuss the latest topics on pharmacometrics and model-informed drug development.  Please add them to your calendar and join us for these sessions:  https://www.certara.com/conference/acop11/

Additionally, we are offering limited spots to meet with our leading pharmacometricians to ask questions on how to most effectively implement model-informed drug development approaches in your program.


临床和经济价值评估

联系我们以了解更多信息

A team of experts may be involved in these sessions as subject matter experts depending on the topic.

Rik de Greef, MsC
SVP and Global Lead,
Quantitative Science Services

rik.degreef@Certara.com

  • Joined Certara in 2014 and trained as a PK/PD scientist at Leiden University and based in the Netherlands
  • Previously, was at Organon, Schering-Plough, and Merck/MSD
  • Key interests in integration of model-based components with overall clinical pharmacology and clinical development

Mark Lovern, PHD
SVP and US Head
of Quantitative Science

mark.lovern@Certara.com

  • Joined Certara in 2014; awarded PhD in biomathematics from North Carolina State University
  • Previously was at GSK, UCB, and Quintiles
  • Broad PK/PD modelling experience across variety of therapeutic areas; taught 50+ training workshops on modelling tools and technology

返回顶部
Powered by Translations.com GlobalLink OneLink Software